Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4944846015 | Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4952188016 | Product containing precisely pyrantel (as pyrantel pamoate) 250 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Is a | Pyrantel only product in oral dose form | true | Inferred relationship | Some | ||
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Has manufactured dose form | Conventional release chewable tablet | true | Inferred relationship | Some | ||
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Plays role | Anthelmintic therapeutic role | true | Inferred relationship | Some | ||
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Has precise active ingredient | Pyrantel pamoate | true | Inferred relationship | Some | 1 | |
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Has BoSS | Pyrantel | true | Inferred relationship | Some | 1 | |
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Pyrantel (as pyrantel pamoate) 250 mg chewable tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR